Zenoxim XP (1000+125) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Ind-Chemie Health Specialities Pvt Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ceftriaxone, Tazobactam. This drug comes in the form of Injection. The general packing available for this medicine consists of 1 Vial and is priced at Rs 132.5 (arround $1.855 US Dollar)
Generic (Salt) Combination :
(Ceftriaxone+ Tazobactam)
Pharma Company :
Ind-Chemie Health Specialities Pvt Ltd.
Brand Label :
Zenoxim XP (1000+125)
Preparation Type :
Injection
Single Dose :
1 Vial
Composition (Fixed-Dose Combination) :
Ceftriaxone-1000 mg
Tazobactam-125 mg
Pack Size/Qty/Vol :
1 Vial
Price Unit :
Rs 132.5 INR (arround $1.855 US Dollar)
Price Pack :
Rs 132.5 INR (arround $1.855 US Dollar)
Drug details for Zenoxim XP (1000+125)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Zenoxim XP (1000+125) are :
Ceftriaxone-1000 mg
Tazobactam-125 mg
Ceftriaxone Indication (Prescribed for or used as): Meningitis, septicaemia, typhoid, UTI, proplylaxis in surgical infections.
For more details on Ceftriaxone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ceftriaxone..
Tazobactam Indication (Prescribed for or used as): Infections caused by Pseudomonas or Klebsiella in neutropenic/immunocompromised patients. Mixed
For more details on Tazobactam, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Tazobactam..
Zenoxim XP (1000+125) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 98 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Zenoxim XP (1000+125), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ceftriaxone-1000 mg Tazobactam-125 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.